Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging

European Journal of Neuroscience

Volumn 30, Issue 6, 2009, Pages 1064-1076

  Madhusudan, Amrita ^a   Sidler, Corinne ^a   Knuesel, Irene ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Choline acetyltransferase; GABAergic neurons; Hippocampal formation; Immunohistochemistry; Mus musculus; Vesicular acetylcholine transporter

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM BINDING PROTEIN; CHOLINE ACETYLTRANSFERASE; PARVALBUMIN; REELIN;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; DIAGONAL BAND OF BROCA; ENTORHINAL CORTEX; FOREBRAIN; HIPPOCAMPUS; MOUSE; NERVE CELL; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; SENILE PLAQUE; SUBSTANTIA INNOMINATA;

AGING; ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL ADHESION MOLECULES, NEURONAL; CELL COUNT; CELL SURVIVAL; CHOLINE O-ACETYLTRANSFERASE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GAMMA-AMINOBUTYRIC ACID; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE TISSUE PROTEINS; NEURONS; ORGAN SIZE; PARVALBUMINS; PROSENCEPHALON; SENILE PLAQUES; SERINE ENDOPEPTIDASES;

EID: 70349213977     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06884.x     Document Type: Article

References (76)

1. Arendt, T., Bigl, V., Arendt, A. Tennstedt, A. (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol., 61, 101 108.
2. Arendt, T., Bigl, V., Walther, F. Sonntag, M. (1984) Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet, 1, 173.
3. Aznavour, N., Mechawar, N. Descarries, L. (2002) Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: a quantitative immunocytochemical study. Hippocampus, 12, 206 217.
4. Bartus, R.T. (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol., 163, 495 529.
5. Beffert, U., Weeber, E.J., Morfini, G., Ko, J., Brady, S.T., Tsai, L.H., Sweatt, J.D. Herz, J. (2004) Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J. Neurosci., 24, 1897 1906.
6. Beffert, U., Weeber, E.J., Durudas, A., Qiu, S., Masiulis, I., Sweatt, J.D., Li, W.P., Adelmann, G., Frotscher, M., Hammer, R.E. Herz, J. (2005) Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron, 47, 567 579.
7. Beffert, U., Durudas, A., Weeber, E.J., Stolt, P.C., Giehl, K.M., Sweatt, J.D., Hammer, R.E. Herz, J. (2006) Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci., 26, 2041 2052.
8. Bierer, L.M., Haroutunian, V., Gabriel, S., Knott, P.J., Carlin, L.S., Purohit, D.P., Perl, D.P., Schmeidler, J., Kanof, P. Davis, K.L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem., 64, 749 760.
9. Bigl, V., Arendt, T., Fischer, S., Fischer, S., Werner, M. Arendt, A. (1987) The cholinergic system in aging. Gerontology, 33, 172 180.
10. Botella-Lopez, A., Burgaya, F., Gavin, R., Garcia-Ayllon, M.S., Gomez-Tortosa, E., Pena-Casanova, J., Urena, J.M., Del Rio, J.A., Blesa, R., Soriano, E. Saez-Valero, J. (2006) Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl Acad. Sci. USA, 103, 5573 5578.
11. Butcher, L.L. Woolf, N.J. (2003) Cholinergic neurons and networks revisited. In Paxinos, G. (Ed The Rat Nervous System, 3rd Edn. Elsevier, USA, pp. 1257 1268.
12. Chen, Y., Beffert, U., Ertunc, M., Tang, T.S., Kavalali, E.T., Bezprozvanny, I. Herz, J. (2005) Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci., 25, 8209 8216.
13. Chin, J., Massaro, C.M., Palop, J.J., Thwin, M.T., Yu, G.Q., Bien-Ly, N., Bender, A. Mucke, L. (2007) Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci., 27, 2727 2733.
14. Contestabile, A., Ciani, E. Contestabile, A. (2008) The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases. Neurochem. Res., 33, 318 327.
15. D'Arcangelo, G., Miao, G.G., Chen, S.C., Soares, H.D., Morgan, J.I. Curran, T. (1995) A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374, 719 723.
16. D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D.S., Sheldon, M. Curran, T. (1999) Reelin is a ligand for lipoprotein receptors. Neuron, 24, 471 479.
17. Dai, J., Buijs, R.M., Kamphorst, W. Swaab, D.F. (2002) Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes. Brain Res., 948, 138 144.
18. Davies, P. Maloney, A.J. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1403.
19. DeKosky, S.T., Ikonomovic, M.D., Styren, S.D., Beckett, L., Wisniewski, S., Bennett, D.A., Cochran, E.J., Kordower, J.H. Mufson, E.J. (2002) Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol., 51, 145 155.
20. Ferrer, I., Zujar, M.J., Rivera, R., Soria, M., Vidal, A. Casas, R. (1993) Parvalbumin-immunoreactive dystrophic neurites and aberrant sprouts in the cerebral cortex of patients with Alzheimer's disease. Neurosci. Lett., 158, 163 166.
21. Finder, V.H. Glockshuber, R. (2007) Amyloid-beta aggregation. Neurodegener Dis., 4, 13 27.
22. Freund, T.F. (1989) GABAergic septohippocampal neurons contain parvalbumin. Brain Res., 478, 375 381.
23. Freund, T.F. Antal, M. (1988) GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature, 336, 170 173.
24. Frolich, L. (2002) The cholinergic pathology in Alzheimer's disease - discrepancies between clinical experience and pathophysiological findings. J. Neural Transm., 109, 1003 1013.
25. Frotscher, M. Leranth, C. (1985) Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: a combined light and electron microscopic study. J. Comp. Neurol., 239, 237 246.
26. Fukaya, M. Watanabe, M. (2000) Improved immunohistochemical detection of postsynaptically located PSD-95/SAP90 protein family by protease section pretreatment: a study in the adult mouse brain. J. Comp. Neurol., 426, 572 586.
27. Gilmor, M.L., Erickson, J.D., Varoqui, H., Hersh, L.B., Bennett, D.A., Cochran, E.J., Mufson, E.J. Levey, A.I. (1999) Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol., 411, 693 704.
28. Gritti, I., Manns, I.D., Mainville, L. Jones, B.E. (2003) Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat. J. Comp. Neurol., 458, 11 31.
29. Gulyas, A.I., Gorcs, T.J. Freund, T.F. (1990) Innervation of different peptide-containing neurons in the hippocampus by GABAergic septal afferents. Neuroscience, 37, 31 44.
30. Han, S.H., McCool, B.A., Murchison, D., Nahm, S.S., Parrish, A.R. Griffith, W.H. (2002) Single-cell RT-PCR detects shifts in mRNA expression profiles of basal forebrain neurons during aging. Brain Res. Mol. Brain Res., 98, 67 80.
31. Hardy, J., Cowburn, R., Barton, A., Reynolds, G., Dodd, P., Wester, P., O'Carroll, A.M., Lofdahl, E. Winblad, B. (1987) A disorder of cortical GABAergic innervation in Alzheimer's disease. Neurosci. Lett., 73, 192 196. (Pubitemid 17223705)
32. Harkany, T., De Jong, G.I., Soos, K., Penke, B., Luiten, P.G. Gulya, K. (1995a) Beta-amyloid (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res., 698, 270 274.
33. Harkany, T., Lengyel, Z., Soos, K., Penke, B., Luiten, P.G. Gulya, K. (1995b) Cholinotoxic effects of beta-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res., 695, 71 75.
34. Hartig, W., Varga, C., Kacza, J., Grosche, J., Seeger, J., Luiten, P.G., Brauer, K. Harkany, T. (2002) In vivo labeling of rabbit cholinergic basal forebrain neurons with fluorochromated antibodies. Neuroreport, 13, 1395 1398.
35. Henny, P. Jones, B.E. (2008) Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur. J. Neurosci., 27, 654 670.
36. Herholz, K., Weisenbach, S. Kalbe, E. (2008) Deficits of the cholinergic system in early AD. Neuropsychologia, 46, 1642 1647.
37. Hiesberger, T., Trommsdorff, M., Howell, B.W., Goffinet, A., Mumby, M.C., Cooper, J.A. Herz, J. (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron, 24, 481 489.
38. Hoe, H.S., Tran, T.S., Matsuoka, Y., Howell, B.W. Rebeck, G.W. (2006) Dab1 and Reelin effects on APP and ApoEr2 trafficking and processing. J. Biol. Chem., 281, 35176 35185.
39. Knuesel, I., Nyffeler, M., Mormede, C., Muhia, M., Meyer, U., Pietropaolo, S., Yee, B.K., Pryce, C.R., LaFerla, F.M., Marighetto, A. Feldon, J. (2009) Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol. Aging, 30, 697 716.
40. Koliatsos, V.E., Kecojevic, A., Troncoso, J.C., Gastard, M.C., Bennett, D.A. Schneider, J.A. (2006) Early involvement of small inhibitory cortical interneurons in Alzheimer's disease. Acta Neuropathol., 112, 147 162.
41. Krzywkowski, P., De Bilbao, F., Senut, M.C. Lamour, Y. (1995) Age-related changes in parvalbumin- and GABA-immunoreactive cells in the rat septum. Neurobiol. Aging, 16, 29 40.
42. Kubo, K., Mikoshiba, K. Nakajima, K. (2002) Secreted Reelin molecules form homodimers. Neurosci. Res., 43, 381 388.
43. Lowe, S.L., Francis, P.T., Procter, A.W., Palmer, A.M., Davison, A.N. Bowen, D.M. (1988) Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain, 111 (Pt 4 785 799.
44. Marczynski, T.J. (1998) GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited. Brain Res. Bull., 45, 341 379.
45. McKinney, M. (2005) Brain cholinergic vulnerability: relevance to behavior and disease. Biochem. Pharmacol., 70, 1115 1124.
46. Miettinen, R., Riedel, A., Kalesnykas, G., Kettunen, H.P., Puolivali, J., Soininen, H. Arendt, T. (2005) Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J. Chem. Neuroanat., 30, 105 118.
47. Morris, J.C. (2002) Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis. Ann. Neurol., 51, 143 144.
48. Motoi, Y., Itaya, M., Mori, H., Mizuno, Y., Iwasaki, T., Hattori, H., Haga, S. Ikeda, K. (2004) Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neurosci. Lett., 368, 144 147.
49. Mufson, E.J., Kroin, J.S., Sendera, T.J. Sobreviela, T. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol., 57, 451 484.
50. Nordberg, A. (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol. Psychiatry, 49, 200 210.
51. Ohkubo, N., Lee, Y.D., Morishima, A., Terashima, T., Kikkawa, S., Tohyama, M., Sakanaka, M., Tanaka, J., Maeda, N., Vitek, M.P. Mitsuda, N. (2003) Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J., 17, 295 297.
52. Pakaski, M. Kalman, J. (2008) Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Neurochem. Int., 53, 103 111.
53. Pakaski, M., Farkas, Z., Kasa, P. Jr., Forgon, M., Papp, H., Zarandi, M., Penke, B. Kasa, P. Sr. (1998) Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide. Brain Res., 796, 239 246.
54. Pascual, M., Perez-Sust, P. Soriano, E. (2004) The GABAergic septohippocampal pathway in control and reeler mice: target specificity and termination onto Reelin-expressing interneurons. Mol. Cell. Neurosci., 25, 679 691.
55. Paxinos, G. Franklin, K. (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd Edn. Academic Press, San Diego, CA, USA.
56. Pesold, C., Impagnatiello, F., Pisu, M.G., Uzunov, D.P., Costa, E., Guidotti, A. Caruncho, H.J. (1998) Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl Acad. Sci. USA, 95, 3221 3226.
57. Qiu, S., Zhao, L.F., Korwek, K.M. Weeber, E.J. (2006) Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J. Neurosci., 26, 12943 12955.
58. Ramos-Moreno, T., Galazo, M.J., Porrero, C., Martinez-Cerdeno, V. Clasca, F. (2006) Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur. J. Neurosci., 23, 401 422.
59. Reinikainen, K.J., Soininen, H. Riekkinen, P.J. (1990) Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res., 27, 576 586.
60. Rice, D.S. Curran, T. (2001) Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci., 24, 1005 1039.
61. Rissman, R.A., De Blas, A.L. Armstrong, D.M. (2007) GABA(A) receptors in aging and Alzheimer's disease. J. Neurochem., 103, 1285 1292.
62. Rossor, M.N., Garrett, N.J., Johnson, A.L., Mountjoy, C.Q., Roth, M. Iversen, L.L. (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain, 105, 313 330.
63. Sarter, M. Bruno, J.P. (2002a) Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data. Ann. Neurol., 52, 384 385.
64. Sarter, M. Bruno, J.P. (2002b) The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections. Eur. J. Neurosci., 15, 1867 1873.
65. Sarter, M. Bruno, J.P. (2004) Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol. Aging, 25, 1127 1139.
66. Schliebs, R. Arendt, T. (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J. Neural Transm., 113, 1625 1644.
67. Seripa, D., Matera, M.G., Franceschi, M., Daniele, A., Bizzarro, A., Rinaldi, M., Panza, F., Fazio, V.M., Gravina, C., D'Onofrio, G., Solfrizzi, V., Masullo, C. Pilotto, A. (2008) The RELN locus in Alzheimer's disease. J. Alzheimers Dis., 14, 335 344.
68. Smith, M.L. Booze, R.M. (1995) Cholinergic and GABAergic neurons in the nucleus basalis region of young and aged rats. Neuroscience, 67, 679 688.
69. Utsunomiya-Tate, N., Kubo, K., Tate, S., Kainosho, M., Katayama, E., Nakajima, K. Mikoshiba, K. (2000) Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl Acad. Sci. USA, 97, 9729 9734.
70. Varga, C., Hartig, W., Grosche, J., Keijser, J., Luiten, P.G., Seeger, J., Brauer, K. Harkany, T. (2003) Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus. J. Comp. Neurol., 460, 597 611.
71. Weeber, E.J., Beffert, U., Jones, C., Christian, J.M., Forster, E., Sweatt, J.D. Herz, J. (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem., 277, 39944 39952.
72. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. Delon, M.R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237 1239.
73. Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Tremp, G., Pradier, L., Beyreuther, K. Bayer, T.A. (2001) Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett., 316, 145 148.
74. Woolf, N.J., Eckenstein, F. Butcher, L.L. (1984) Cholinergic systems in the rat brain: I. projections to the limbic telencephalon. Brain Res. Bull., 13, 751 784.
75. Woolf, N.J., Hernit, M.C. Butcher, L.L. (1986) Cholinergic and non-cholinergic projections from the rat basal forebrain revealed by combined choline acetyltransferase and Phaseolus vulgaris leucoagglutinin immunohistochemistry. Neurosci. Lett., 66, 281 286.
76. Zaborszky, L., Buhl, D.L., Pobalashingham, S., Bjaalie, J.G. Nadasdy, Z. (2005) Three-dimensional chemoarchitecture of the basal forebrain: spatially specific association of cholinergic and calcium binding protein-containing neurons. Neuroscience, 136, 697 713.